RETRACTED ARTICLE: LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis

Statement of Retraction

We, the Editors and Publisher of the journal Cell Cycle, have retracted the following article:

Qiaosu Wang, Wenjing Zhang and Shaojuan Hao. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis. Cell Cycle. 2017;16(8):795-801. doi: 10.1080/15384101.2017.1301334

Since publication, the authors have raised concerns about the reliability of the data presented in the article. As the Editor and Publisher also have significant concerns about the integrity of the reported results, all parties have agreed to retract the article to ensure correction of the scholarly record.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:

Statement of Retraction: LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis